Home
Storia in 1 fonti
More studies tie GLP-1s to small risks for eye complications
GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies recently published in Annals of Internal Medicine show. Prior evidence on the ties between eye complications and GLP-1s has been mixed. A 2025 analysis indicated that semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly) raise the risk for
Raccontata da
healio.com
Timeline cronologica
- ·
More studies tie GLP-1s to small risks for eye complications
GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies recently published in Annals of Internal Medicine…
- ·
GLP-1s may raise risk for smell, taste disturbances in type 2 diabetes
Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA…